Image

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

RISE study supports fairness in high-risk neuroblastoma care.

Recruiting
17 years and younger
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Resource Intervention to Support Equity (RISE) is a study for children with high-risk neuroblastoma, a type of cancer. The study aims to see if extra help, called Pediatric RISE, can improve outcomes for children from low-income families. Neuroblastoma is a cancer that often starts in the small glands on top of the kidneys. Participants will be picked randomly to receive either regular care or regular care with Pediatric RISE help. The study lasts about 6 months, and will involve visits or online meetings, as well as filling out surveys.

  • Study Duration: Participation will last approximately 6 months.
  • Visits: Participants will have in-person or virtual appointments.
  • Eligibility: Only children from low-income families with high-risk neuroblastoma can join.

To be part of this study, children should be under 18, diagnosed with high-risk neuroblastoma, and living in certain states like MA, PA, IL, CA, WA, CT, GA, WI, or OH. Families with a low income are eligible. However, families receiving special government benefits are not eligible.

Print
Study details
    Neuroblastoma
    High-risk Neuroblastoma

NCT06831552

Dana-Farber Cancer Institute

7 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.